A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
10.1038/sj.gt.3302304
Crossref journal-article
Springer Science and Business Media LLC
Gene Therapy (297)
Bibliography

Yu, W., Pirollo, K., Rait, A., Yu, B., Xiang, L., Huang, W., Zhou, Q., Ertem, G., & Chang, E. (2004). A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Therapy, 11(19), 1434–1440.

Authors 9
  1. W Yu (first)
  2. KF Pirollo (additional)
  3. A Rait (additional)
  4. B Yu (additional)
  5. LM Xiang (additional)
  6. WQ Huang (additional)
  7. Q Zhou (additional)
  8. G Ertem (additional)
  9. EH Chang (additional)
References 28 Referenced 69
  1. Fenske DB, MacLachlan I, Cullis PR . Stabilized plasmid–lipid particles: a systemic gene therapy vector. Methods Enzymol 2002; 346: 36–71. (10.1016/S0076-6879(02)46048-X) / Methods Enzymol by DB Fenske (2002)
  2. Woodle MC, Lasic DD . Sterically stabilized liposomes. Biochim Biophys Acta 1992; 1113: 171–199. (10.1016/0304-4157(92)90038-C) / Biochim Biophys Acta by MC Woodle (1992)
  3. Blessing T et al. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjugate Chem 2001; 12: 529–537. (10.1021/bc0001488) / Bioconjugate Chem by T Blessing (2001)
  4. Guo W, Lee RL . Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS Pharm Sci 1999; 1: E19. (10.1208/ps010419) / AAPS Pharm Sci by W Guo (1999)
  5. Chluba J, Lima DS, Frisch B, Schuber F . Enhancement of gene delivery by an analogue of alpha-MSH in a receptor-independent fashion. Biochim Biophys Acta 2001; 1510: 198–208. (10.1016/S0005-2736(00)00348-5) / Biochim Biophys Acta by J Chluba (2001)
  6. Pun SH, Davis ME . Development of a nonviral gene delivery vehicle for systemic application. Bioconjugate Chem 2002; 13: 630–639. (10.1021/bc0155768) / Bioconjugate Chem by SH Pun (2002)
  7. Hofland HE et al. Folate-targeted gene transfer in vivo. Mol Ther 2002; 5: 739–744. (10.1006/mthe.2002.0604) / Mol Ther by HE Hofland (2002)
  8. Kircheis R et al. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther 2002; 9: 731–735. (10.1038/sj.gt.3301748) / Gene Ther by R Kircheis (2002)
  9. Kursa M et al. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjugate Chem 2003; 14: 222–231. (10.1021/bc0256087) / Bioconjugate Chem by M Kursa (2003)
  10. Ogris M et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595–605. (10.1038/sj.gt.3300900) / Gene Ther by M Ogris (1999)
  11. Kichler A et al. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release 2002; 81: 379–388. (10.1016/S0168-3659(02)00080-9) / J Control Release by A Kichler (2002)
  12. Gabizon A et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem 1999; 10: 289–298. (10.1021/bc9801124) / Bioconjugate Chem by A Gabizon (1999)
  13. Song LY et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002; 1558: 1–13. (10.1016/S0005-2736(01)00399-6) / Biochim Biophys Acta by LY Song (2002)
  14. Shi F et al. Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem J 2002; 366: 333–341. (10.1042/bj20020590) / Biochem J by F Shi (2002)
  15. Audouy S, de Leij L, Hoekstra D, Molema G . In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm Res 2002; 19: 1599–1605. (10.1023/A:1020989709019) / Pharm Res by S Audouy (2002)
  16. Xu L, Pirollo KF, Chang EH . Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther 1997; 8: 467–475. (10.1089/hum.1997.8.4-467) / Hum Gene Ther by L Xu (1997)
  17. Xu L, Pirollo KF, Chang EH, Murray A . Systemic p53 gene therapy in combination with radiation results in human tumor regression. Tumor Targeting 1999; 4: 92–104. / Tumor Targeting by L Xu (1999)
  18. Xu L et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999; 10: 2941–2952. (10.1089/10430349950016357) / Hum Gene Ther by L Xu (1999)
  19. Xu L, Pirollo KF, Chang EH . Tumor-targeted p53 gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release 2001; 6: 115–128. (10.1016/S0168-3659(01)00324-8) / J Control Release by L Xu (2001)
  20. Xu L et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 2001; 7: 723–734. (10.1007/BF03401962) / Mol Med by L Xu (2001)
  21. Xu L et al. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum Gene Ther 2002; 13: 469–481. (10.1089/10430340252792594) / Hum Gene Ther by L Xu (2002)
  22. Xu L et al. Systemic tumor-targeted gene delivery by anti-Transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002; 1: 337–346. / Mol Cancer Ther by L Xu (2002)
  23. Maruyama K, Ishida O, Takizawa T, Moribe K . Possibility of active targeting to tumor tissues with liposomes. Adv Drug Del Rev 1999; 40: 89–102. (10.1016/S0169-409X(99)00042-3) / Adv Drug Del Rev by K Maruyama (1999)
  24. Barron LG, Meyer KB, Szoka FC . Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum Gene Ther 1998; 9: 315–323. (10.1089/hum.1998.9.3-315) / Hum Gene Ther by LG Barron (1998)
  25. Dash PR et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643–650. (10.1038/sj.gt.3300843) / Gene Ther by PR Dash (1999)
  26. Nishikawa M, Huang L . Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861–870. (10.1089/104303401750195836) / Hum Gene Ther by M Nishikawa (2001)
  27. Chesnoy S, Huang L . Structure and function of lipid–DNA complexes for gene delivery. Annu Rev Biophys Biomol Struct 2000; 29: 27–47. (10.1146/annurev.biophys.29.1.27) / Annu Rev Biophys Biomol Struct by S Chesnoy (2000)
  28. Yu W et al. Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide. Nucleic Acids Res 2004; 32: e48. (10.1093/nar/gnh049) / Nucleic Acids Res by W Yu (2004)
Dates
Type When
Created 21 years, 1 month ago (July 1, 2004, 5:33 a.m.)
Deposited 3 years, 4 months ago (March 30, 2022, 12:33 a.m.)
Indexed 3 months, 4 weeks ago (April 25, 2025, 6:43 p.m.)
Issued 21 years, 1 month ago (July 1, 2004)
Published 21 years, 1 month ago (July 1, 2004)
Published Online 21 years, 1 month ago (July 1, 2004)
Published Print 20 years, 10 months ago (Oct. 1, 2004)
Funders 0

None

@article{Yu_2004, title={A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene}, volume={11}, ISSN={1476-5462}, url={http://dx.doi.org/10.1038/sj.gt.3302304}, DOI={10.1038/sj.gt.3302304}, number={19}, journal={Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Yu, W and Pirollo, KF and Rait, A and Yu, B and Xiang, LM and Huang, WQ and Zhou, Q and Ertem, G and Chang, EH}, year={2004}, month=jul, pages={1434–1440} }